SCHEMBL20182258

SCHEMBL20182258

O=C(Cc1c[nH]c2ccc(O)cc12)Nc1ccc(F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
NPSR1 Q6W5P4 5/20 0.59
TSHR P16473 4/20 0.59
LMNA P02545 3/20 0.59
HPGD P15428 2/20 0.59
NFKB1 P19838 2/20 0.59
PMP22 Q01453 2/20 0.59
CYP2C9 P11712 2/20 0.59
GLA P06280 1/20 0.59
NR4A1 P22736 1/20 0.56
ANO1 Q5XXA6 1/20 0.54
MAPT P10636 5/20 0.49
KDM4E B2RXH2 4/20 0.49
CYP3A4 P08684 3/20 0.49
CYP2D6 P10635 3/20 0.49
SPR P35270 2/20 0.49
BLM P54132 2/20 0.49
CYP1A2 P05177 2/20 0.49
IDO1 P14902 1/20 0.49
NOTUM Q6P988 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182260 0.85 SPR (0.49) ALDH1A1NPSR1TSHRLMNAHPGD
SCHEMBL18229461 0.83 HRH3 (0.65) ALDH1A1LMNAGLAMAPTHRH3
SCHEMBL8812559 0.81 TSHR (0.60) TSHRANO1SPRNOTUMHTR2A
SCHEMBL31127587 0.80 ANO1 (0.52) TSHRANO1MAPT
SCHEMBL20182375 0.80 NPSR1 (0.70) ALDH1A1NPSR1TSHRLMNAHPGD
SCHEMBL27333111 0.79 HRH3 (0.67) ALDH1A1LMNACYP2C9GLAMAPT
SCHEMBL20182374 0.79 NPSR1 (0.68) ALDH1A1NPSR1TSHRLMNAHPGD
SCHEMBL30275168 0.76 ANO1 (0.55) ALDH1A1TSHRLMNACYP2C9ANO1
SCHEMBL5188723 0.76 TSHR (0.71) TSHRANO1SPRNOTUMHTR1A
SCHEMBL20182400 0.75 SPR (0.51) ALDH1A1NPSR1TSHRLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352326-B2 Myeloperoxidase imaging agents THE GENERAL HOSPITAL CORPORATION (US) 2022-06-07 US disclosed
US-20190315689-A1 Myeloperoxidase Imaging Agents THE GENERAL HOSPITAL CORPORATION 2019-10-17 US disclosed
WO-2018094005-A1 MYELOPEROXIDASE IMAGING AGENTS THE GENERAL HOSPITAL CORPORATION (US) 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190315689-A1 Myeloperoxidase Imaging Agents MPO, CAT, EPX ALDH1A1 176/4885NPSR1 1268/4885TSHR 2257/4885
US-11352326-B2 Myeloperoxidase imaging agents MPO, CAT, EPX ALDH1A1 176/4885NPSR1 1268/4885TSHR 2257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.